Medical research

Stanford developing single-dose nanoparticle vaccine for COVID-19

Before the pandemic, the lab of Stanford University biochemist Peter S. Kim focused on developing vaccines for HIV, Ebola and pandemic influenza. But, within days of closing their campus lab space as part of COVID-19 precautions, ...

Diseases, Conditions, Syndromes

What should a successful SARS-CoV-2 vaccine do?

A lot has been written recently about the merits of different potential vaccines for SARS-CoV-2. "Merit" is generally assumed to mean that the vaccine will make us immune. But what, exactly, is immunity, and how would we ...

Diseases, Conditions, Syndromes

Some COVID-19 mutations may dampen vaccine effectiveness

Scientists are reporting troubling signs that some recent mutations of the virus that causes COVID-19 may modestly curb the effectiveness of two current vaccines, although they stress that the shots still protect against ...

page 1 from 187